Satralizumab Treatment in Chinese Patients with AQP4-ab-positive Neuromyelitis Optica Specturm Disorder: A Prospective Study (P9-1.015)

To estimate the efficacy and safety of satralizumab in a prospective population of Chinese patients with AQP4+ NMOSD.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211195
Primary Topic
Protein Tyrosine Phosphatases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Satralizumab Treatment in Chinese Patients with AQP4-ab-positive Neuromyelitis Optica Specturm Disorder: A Prospective Study (P9-1.015)

Wenjuan Huang, Qiang Dong, Jingzi ZhangBao, Chao Quan
1 links
Neurology
Protein Tyrosine Phosphatases
article

Satralizumab Treatment in Chinese Patients with AQP4-ab-positive Neuromyelitis Optica Specturm Disorder: A Prospective Study (P9-1.015)

Wenjuan Huang, Qiang Dong, Jingzi ZhangBao, Chao Quan
article en

Abstract

To estimate the efficacy and safety of satralizumab in a prospective population of Chinese patients with AQP4+ NMOSD.

NeurologyVol. 104(7_Supplement_1)
Fudan University (CN), Huashan Hospital (CN)
Good health and well-being
Openalex Percentile: Top 94%
Protein Tyrosine Phosphatases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Satralizumab Treatment in Chinese Patients with AQP4-ab-positive Neuromyelitis Optica Specturm Disorder: A Prospective Study (P9-1.015) — Wenjuan Huang, Qiang Dong, et al. · Neurology (2025) | TGRS Research Map | TGRS